Description: Experts' discussion of data sources, quality, and analysis. From 2005 Living to 100 and Beyond Monograph, M-LI05-1.

Description: This paper focuses on the situation of women at high ages and the implications of longer life for women. This paper draws on and brings together work done by the Society of Actuaries in connection with the 2005 post-retirement risk survey, work from Social Security administration studies, U.S. government census data, WISER, the MetLife Mature Market Institute and papers funded by the Social Security research center.

Description: A multiway typology of measures of aging, longevity and superlongevity is presented, with measures classified as measures of aging and longevity, direct and indirect measures of aging and longevity, and measures based on population data, death statistics and life table functions.

Description: This paper discusses the increasing body of demographic, genetic and medical data being generated from studies of centenarians and the increasingly greater genetic contribution to the ability to survive to ages beyond 100.

Description: We suggest a new method of latent variable analysis and apply it for describing mortality changes in developed countries over the period of 1900--2014.

Description: This is the General Session V transcript on the Nitty Gritty of Human Morality Database from the January 4-6, 2017 Living to 100 Symposium in Orlando

Description: Three papers use sophisticated actuarial methods to develop a straightforward retirement income strategy that can be implemented in virtually any IRA or 401(k).

Description: This article covers subjects discussed at the 2011 Living To 100 Symposium. Included were the real potential of a material extension of life and economic challenges associated such an occurrence.

Description: Pricing longevity swap reinsurance transactions consists of a number of different actuarial tasks, each of which hides potential pitfalls. The article outlines the pricing process, which includes a detailed analysis of current mortality experience of the portfolio to be transferred, choice and calibration of an appropriate model for mortality improvement trends and the calculation of a risk margin which reflects the uncertainty associated with the pricing best-estimate, which includes mis-estimation risk, model risk, longevity basis risk and stochastic uncertainty.